In the STEP trials, semaglutide 2.4mg weekly resulted in mean weight reductions of 1517% over 68 weeks, whilst tirzepatide in the SURPASS trials showed reductions of 1520% (Kushner et al
Complete Blood Count (CBC) Why it matters: A CBC with differential provides a baseline assessment of red blood cells, white blood cells, and platelets
doi: 10.3390/jcm11071995 28 MohantyR
When that hormone is amplified through medication, it reduces appetite, slows the rate at which your stomach empties, and improves insulin sensitivity
No journal article, no conference abstract, no press release
Multiple studies have found no significant difference in HbA1c reduction or weight loss between morning and evening injection timing